HEADER TRANSFERASE 04-MAY-07 2PS1 TITLE S. CEREVISIAE OROTATE PHOSPHORIBOSYLTRANSFERASE COMPLEXED WITH OROTIC TITLE 2 ACID AND PRPP COMPND MOL_ID: 1; COMPND 2 MOLECULE: OROTATE PHOSPHORIBOSYLTRANSFERASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: OPRT 1, OPRTASE 1; COMPND 5 EC: 2.4.2.10; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE; SOURCE 3 ORGANISM_COMMON: BAKER'S YEAST; SOURCE 4 ORGANISM_TAXID: 4932; SOURCE 5 GENE: URA5, PYR5; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: CS101-4UI; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PTRC99A; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PREJ2 KEYWDS ALPHA BETA, OPRTASE-OA-PRPP COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR L.GONZALEZ-SEGURA,T.D.HURLEY,R.W.MCCLARD REVDAT 6 30-AUG-23 2PS1 1 HETSYN REVDAT 5 29-JUL-20 2PS1 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE REVDAT 4 18-OCT-17 2PS1 1 REMARK REVDAT 3 13-JUL-11 2PS1 1 VERSN REVDAT 2 24-FEB-09 2PS1 1 VERSN REVDAT 1 15-JAN-08 2PS1 0 JRNL AUTH L.GONZALEZ-SEGURA,J.F.WITTE,R.W.MCCLARD,T.D.HURLEY JRNL TITL TERNARY COMPLEX FORMATION AND INDUCED ASYMMETRY IN OROTATE JRNL TITL 2 PHOSPHORIBOSYLTRANSFERASE. JRNL REF BIOCHEMISTRY V. 46 14075 2007 JRNL REFN ISSN 0006-2960 JRNL PMID 18020427 JRNL DOI 10.1021/BI701023Z REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.7 REMARK 3 NUMBER OF REFLECTIONS : 36660 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1844 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.79 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1604 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 57.99 REMARK 3 BIN R VALUE (WORKING SET) : 0.2640 REMARK 3 BIN FREE R VALUE SET COUNT : 87 REMARK 3 BIN FREE R VALUE : 0.2500 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3446 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 68 REMARK 3 SOLVENT ATOMS : 322 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.25 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.63 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.24000 REMARK 3 B22 (A**2) : 0.32000 REMARK 3 B33 (A**2) : 0.08000 REMARK 3 B12 (A**2) : 0.09000 REMARK 3 B13 (A**2) : 1.14000 REMARK 3 B23 (A**2) : 0.63000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.157 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.131 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.089 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.715 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.946 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3562 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4814 ; 1.110 ; 1.995 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 446 ; 4.831 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 144 ;33.196 ;25.278 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 640 ;14.733 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;10.863 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 558 ; 0.069 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2584 ; 0.002 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1821 ; 0.180 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2552 ; 0.298 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 314 ; 0.091 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 95 ; 0.139 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 37 ; 0.111 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2288 ; 0.484 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3546 ; 0.853 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1442 ; 0.982 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1268 ; 1.536 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2PS1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-MAY-07. REMARK 100 THE DEPOSITION ID IS D_1000042719. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-APR-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36660 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.200 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.9 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.04900 REMARK 200 R SYM (I) : 0.04300 REMARK 200 FOR THE DATA SET : 17.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 63.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : 0.25100 REMARK 200 R SYM FOR SHELL (I) : 0.21100 REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2PRZ (S. CEREVISIAE OPRTASE COMPLEXED REMARK 200 WITH OMP) REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 38% PEG 4000, 0.14M AMMONIUM ACETATE, REMARK 280 0.1M SODIUM ACETATE, 2.0MM MAGNESIUM CHLORIDE, 5.0MM PRPP, 5.0MM REMARK 280 OROTIC ACID, PH 4.6, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 288.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 5670 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -56.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 PRO A 1 REMARK 465 MET B 0 REMARK 465 PRO B 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU B 215 CD GLU B 215 OE2 0.075 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 94 -12.45 -145.18 REMARK 500 THR A 135 -78.24 -113.21 REMARK 500 ARG A 205 58.93 -148.01 REMARK 500 ALA A 208 3.49 84.23 REMARK 500 GLU A 209 -41.92 -162.04 REMARK 500 THR B 135 -79.42 -111.63 REMARK 500 GLU B 203 -124.64 52.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 401 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 PRP A 700 O2 REMARK 620 2 PRP A 700 O3B 97.8 REMARK 620 3 HOH A 721 O 148.8 99.9 REMARK 620 4 HOH A 834 O 102.4 97.3 100.6 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 402 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 PRP B 800 O3B REMARK 620 2 PRP B 800 O2 96.3 REMARK 620 3 HOH B 833 O 99.1 146.9 REMARK 620 4 HOH B 877 O 96.3 107.5 99.7 REMARK 620 N 1 2 3 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2PRY RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN THE APO FORM REMARK 900 RELATED ID: 2PRZ RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH OMP DBREF 2PS1 A 0 225 UNP P13298 PYRE_YEAST 1 226 DBREF 2PS1 B 0 225 UNP P13298 PYRE_YEAST 1 226 SEQRES 1 A 226 MET PRO ILE MET LEU GLU ASP TYR GLN LYS ASN PHE LEU SEQRES 2 A 226 GLU LEU ALA ILE GLU CYS GLN ALA LEU ARG PHE GLY SER SEQRES 3 A 226 PHE LYS LEU LYS SER GLY ARG GLU SER PRO TYR PHE PHE SEQRES 4 A 226 ASN LEU GLY LEU PHE ASN THR GLY LYS LEU LEU SER ASN SEQRES 5 A 226 LEU ALA THR ALA TYR ALA ILE ALA ILE ILE GLN SER ASP SEQRES 6 A 226 LEU LYS PHE ASP VAL ILE PHE GLY PRO ALA TYR LYS GLY SEQRES 7 A 226 ILE PRO LEU ALA ALA ILE VAL CYS VAL LYS LEU ALA GLU SEQRES 8 A 226 ILE GLY GLY SER LYS PHE GLN ASN ILE GLN TYR ALA PHE SEQRES 9 A 226 ASN ARG LYS GLU ALA LYS ASP HIS GLY GLU GLY GLY ILE SEQRES 10 A 226 ILE VAL GLY SER ALA LEU GLU ASN LYS ARG ILE LEU ILE SEQRES 11 A 226 ILE ASP ASP VAL MET THR ALA GLY THR ALA ILE ASN GLU SEQRES 12 A 226 ALA PHE GLU ILE ILE SER ASN ALA LYS GLY GLN VAL VAL SEQRES 13 A 226 GLY SER ILE ILE ALA LEU ASP ARG GLN GLU VAL VAL SER SEQRES 14 A 226 THR ASP ASP LYS GLU GLY LEU SER ALA THR GLN THR VAL SEQRES 15 A 226 SER LYS LYS TYR GLY ILE PRO VAL LEU SER ILE VAL SER SEQRES 16 A 226 LEU ILE HIS ILE ILE THR TYR LEU GLU GLY ARG ILE THR SEQRES 17 A 226 ALA GLU GLU LYS SER LYS ILE GLU GLN TYR LEU GLN THR SEQRES 18 A 226 TYR GLY ALA SER ALA SEQRES 1 B 226 MET PRO ILE MET LEU GLU ASP TYR GLN LYS ASN PHE LEU SEQRES 2 B 226 GLU LEU ALA ILE GLU CYS GLN ALA LEU ARG PHE GLY SER SEQRES 3 B 226 PHE LYS LEU LYS SER GLY ARG GLU SER PRO TYR PHE PHE SEQRES 4 B 226 ASN LEU GLY LEU PHE ASN THR GLY LYS LEU LEU SER ASN SEQRES 5 B 226 LEU ALA THR ALA TYR ALA ILE ALA ILE ILE GLN SER ASP SEQRES 6 B 226 LEU LYS PHE ASP VAL ILE PHE GLY PRO ALA TYR LYS GLY SEQRES 7 B 226 ILE PRO LEU ALA ALA ILE VAL CYS VAL LYS LEU ALA GLU SEQRES 8 B 226 ILE GLY GLY SER LYS PHE GLN ASN ILE GLN TYR ALA PHE SEQRES 9 B 226 ASN ARG LYS GLU ALA LYS ASP HIS GLY GLU GLY GLY ILE SEQRES 10 B 226 ILE VAL GLY SER ALA LEU GLU ASN LYS ARG ILE LEU ILE SEQRES 11 B 226 ILE ASP ASP VAL MET THR ALA GLY THR ALA ILE ASN GLU SEQRES 12 B 226 ALA PHE GLU ILE ILE SER ASN ALA LYS GLY GLN VAL VAL SEQRES 13 B 226 GLY SER ILE ILE ALA LEU ASP ARG GLN GLU VAL VAL SER SEQRES 14 B 226 THR ASP ASP LYS GLU GLY LEU SER ALA THR GLN THR VAL SEQRES 15 B 226 SER LYS LYS TYR GLY ILE PRO VAL LEU SER ILE VAL SER SEQRES 16 B 226 LEU ILE HIS ILE ILE THR TYR LEU GLU GLY ARG ILE THR SEQRES 17 B 226 ALA GLU GLU LYS SER LYS ILE GLU GLN TYR LEU GLN THR SEQRES 18 B 226 TYR GLY ALA SER ALA HET MG A 401 1 HET ORO A 500 11 HET PRP A 700 22 HET MG B 402 1 HET ORO B 600 11 HET PRP B 800 22 HETNAM MG MAGNESIUM ION HETNAM ORO OROTIC ACID HETNAM PRP 1-O-PYROPHOSPHONO-5-O-PHOSPHONO-ALPHA-D-RIBOFURANOSE HETSYN PRP ALPHA-PHOSPHORIBOSYLPYROPHOSPHORIC ACID; 1-O- HETSYN 2 PRP PYROPHOSPHONO-5-O-PHOSPHONO-ALPHA-D-RIBOSE; 1-O- HETSYN 3 PRP PYROPHOSPHONO-5-O-PHOSPHONO-D-RIBOSE; 1-O- HETSYN 4 PRP PYROPHOSPHONO-5-O-PHOSPHONO-RIBOSE FORMUL 3 MG 2(MG 2+) FORMUL 4 ORO 2(C5 H4 N2 O4) FORMUL 5 PRP 2(C5 H13 O14 P3) FORMUL 9 HOH *322(H2 O) HELIX 1 1 GLU A 5 CYS A 18 1 14 HELIX 2 2 LEU A 40 PHE A 43 5 4 HELIX 3 3 THR A 45 ASP A 64 1 20 HELIX 4 4 LYS A 76 GLY A 92 1 17 HELIX 5 5 GLY A 137 ALA A 150 1 14 HELIX 6 6 SER A 176 GLY A 186 1 11 HELIX 7 7 LEU A 195 GLU A 203 1 9 HELIX 8 8 GLY A 204 ILE A 206 5 3 HELIX 9 9 GLU A 209 GLY A 222 1 14 HELIX 10 10 GLU B 5 CYS B 18 1 14 HELIX 11 11 LEU B 40 PHE B 43 5 4 HELIX 12 12 THR B 45 ASP B 64 1 20 HELIX 13 13 LYS B 76 GLY B 92 1 17 HELIX 14 14 GLY B 93 GLN B 97 5 5 HELIX 15 15 GLY B 137 ALA B 150 1 14 HELIX 16 16 SER B 176 GLY B 186 1 11 HELIX 17 17 LEU B 195 GLU B 203 1 9 HELIX 18 18 GLY B 204 ILE B 206 5 3 HELIX 19 19 THR B 207 GLY B 222 1 16 SHEET 1 A 2 LEU A 21 LYS A 27 0 SHEET 2 A 2 GLU A 33 PHE A 38 -1 O SER A 34 N PHE A 26 SHEET 1 B 6 GLY A 115 GLY A 119 0 SHEET 2 B 6 GLN A 100 LYS A 109 -1 N PHE A 103 O VAL A 118 SHEET 3 B 6 VAL A 69 GLY A 72 1 N ILE A 70 O GLN A 100 SHEET 4 B 6 ARG A 126 MET A 134 1 O LEU A 128 N PHE A 71 SHEET 5 B 6 GLN A 153 ASP A 162 1 O ILE A 158 N ILE A 129 SHEET 6 B 6 VAL A 189 SER A 194 1 O LEU A 190 N SER A 157 SHEET 1 C 2 LEU B 21 LYS B 27 0 SHEET 2 C 2 GLU B 33 PHE B 38 -1 O PHE B 37 N ARG B 22 SHEET 1 D 6 GLY B 115 GLY B 119 0 SHEET 2 D 6 GLN B 100 LYS B 109 -1 N PHE B 103 O VAL B 118 SHEET 3 D 6 VAL B 69 GLY B 72 1 N ILE B 70 O GLN B 100 SHEET 4 D 6 ARG B 126 MET B 134 1 O LEU B 128 N PHE B 71 SHEET 5 D 6 GLN B 153 ASP B 162 1 O GLN B 153 N ILE B 127 SHEET 6 D 6 VAL B 189 SER B 194 1 O LEU B 190 N SER B 157 LINK MG MG A 401 O2 PRP A 700 1555 1555 2.46 LINK MG MG A 401 O3B PRP A 700 1555 1555 2.31 LINK MG MG A 401 O HOH A 721 1555 1555 2.23 LINK MG MG A 401 O HOH A 834 1555 1555 2.21 LINK MG MG B 402 O3B PRP B 800 1555 1555 2.31 LINK MG MG B 402 O2 PRP B 800 1555 1555 2.48 LINK MG MG B 402 O HOH B 833 1555 1555 2.37 LINK MG MG B 402 O HOH B 877 1555 1555 2.27 CISPEP 1 ALA A 74 TYR A 75 0 -1.90 CISPEP 2 THR A 207 ALA A 208 0 13.42 CISPEP 3 ALA B 74 TYR B 75 0 -0.60 CRYST1 41.788 50.051 50.078 90.59 105.88 92.99 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023930 0.001250 0.006842 0.00000 SCALE2 0.000000 0.020007 0.000512 0.00000 SCALE3 0.000000 0.000000 0.020768 0.00000